Table 3 Listing of adverse events. Safety analysis set
Item | Grade 1–2 n (%) | Grade ≥ 3 n (%) |
|---|---|---|
Any adverse event | 15 (88.2%) | 0 |
Vomiting | 3 (17.6%) | 0 |
Abdominal Pain | 2 (11.8%) | 0 |
Ascites | 1 (5.9%) | 0 |
Dyspepsia | 1 (5.9%) | 0 |
Nausea | 1 (5.9%) | 0 |
Paresthesia | 2 (11.8%) | 0 |
Headache | 1 (5.9%) | 0 |
Dizziness | 1 (5.9%) | 0 |
Seizure | 1 (5.9%) | 0 |
Anemia | 4 (23.5%) | 0 |
Platelet count decreased | 1 (5.9%) | 0 |
Fatigue | 4 (23.5%) | 0 |
Skin infection | 2 (11.8%) | 0 |
Agitation | 1 (5.9%) | 0 |
Confusion | 1 (5.9%) | 0 |
Pain of skin | 1 (5.9%) | 0 |
Pruritus | 1 (5.9%) | 0 |
Hypoxia | 1 (5.9%) | 0 |
Creatinine increased | 1 (5.9%) | 0 |
Hyperglicemia | 1 (5.9%) | 0 |
Neck pain | 1 (5.9%) | 0 |
Pain in extremity | 1 (5.9%) | 0 |
Tumor pain | 1 (5.9%) | 0 |